Journal
PHARMACEUTICAL PATENT ANALYST
Volume -, Issue -, Pages -Publisher
Newlands Press Ltd
DOI: 10.4155/ppa-2023-0015
Keywords
brain cancer; breast cancer; drug repurposing; lung cancer; mito-atovaquone; pancreatic cancer
Categories
Ask authors/readers for more resources
Research shows that mito-Atovaquone can be used to treat various types of cancer, including pancreatic cancer, lung cancer, and brain cancer. The repurposing of this approved drug strategy saves time and investment.
Repurposing of approved drugs in a new strategy to combat cancer that leads to savings in time and investment. Atovaquone is a US FDA approved drug for treatment of Pneumocystis carinii pneumonia and malaria. Patent US2023017373 describe the use of mito-atovaquone for the treatment of several types of cancer. Mito-Atovaquone demonstrated antiproliferative activity in cell lines of pancreatic cancer, lung cancer and brain cancer and inhibited tumor growth in syngeneic mouse models and in animals genetically prone to breast cancer. Mito-Atovaquone has the potential to be used successfully in the treatment of various types of tumors.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available